International Patent: ENGINEERED IMMUNE CELLS EXPRESSING ANTI-PABPC1 OR ANTI-PABPC4 ANTIBODIES AND USES THEREOF

GENEVA, July 1 -- MEMORIAL SLOAN-KETTERING CANCER CENTER filed a patent application (US2025/049662) for “ENGINEERED IMMUNE CELLS EXPRESSING ANTI-PABPC1 OR ANTI-PABPC4 ANTIBODIES AND USES THEREOF”. With publication no. WO/2026/080384, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C07K 16/44

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....